PortfoliosLab logoPortfoliosLab logo
NKT.CO vs. ZEAL.CO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

NKT.CO vs. ZEAL.CO - Performance Comparison

The chart below illustrates the hypothetical performance of a DKK 10,000 investment in NKT A/S (NKT.CO) and Zealand Pharma A/S (ZEAL.CO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, NKT.CO achieves a 22.79% return, which is significantly higher than ZEAL.CO's -36.58% return. Over the past 10 years, NKT.CO has outperformed ZEAL.CO with an annualized return of 21.65%, while ZEAL.CO has yielded a comparatively lower 10.55% annualized return.


NKT.CO

1D
-0.15%
1M
-7.15%
YTD
22.79%
6M
23.26%
1Y
82.25%
3Y*
33.49%
5Y*
31.24%
10Y*
21.65%

ZEAL.CO

1D
0.51%
1M
-4.76%
YTD
-36.58%
6M
-39.98%
1Y
-37.65%
3Y*
2.31%
5Y*
8.36%
10Y*
10.55%
*Multi-year figures are annualized to reflect compound growth (CAGR)

NKT.CO vs. ZEAL.CO - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
NKT.CO
NKT A/S
22.79%55.20%10.93%29.04%24.02%16.37%90.92%80.78%-68.60%14.20%
ZEAL.CO
Zealand Pharma A/S
-36.58%-34.81%91.72%85.30%38.80%-34.22%-6.29%185.68%-3.06%-20.19%

Correlation

The correlation between NKT.CO and ZEAL.CO is 0.30, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.30

Correlation (3Y)
Calculated over the trailing 3-year period

0.24

Correlation (5Y)
Calculated over the trailing 5-year period

0.28

Correlation (10Y)
Calculated over the trailing 10-year period

0.27

Correlation (All Time)
Calculated using the full available price history since Nov 23, 2010

0.25

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NKT.CO vs. ZEAL.CO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NKT.CO
NKT.CO Risk / Return Rank: 9292
Overall Rank
NKT.CO Sharpe Ratio Rank: 9191
Sharpe Ratio Rank
NKT.CO Sortino Ratio Rank: 9292
Sortino Ratio Rank
NKT.CO Omega Ratio Rank: 8888
Omega Ratio Rank
NKT.CO Calmar Ratio Rank: 9595
Calmar Ratio Rank
NKT.CO Martin Ratio Rank: 9595
Martin Ratio Rank

ZEAL.CO
ZEAL.CO Risk / Return Rank: 1818
Overall Rank
ZEAL.CO Sharpe Ratio Rank: 1818
Sharpe Ratio Rank
ZEAL.CO Sortino Ratio Rank: 2323
Sortino Ratio Rank
ZEAL.CO Omega Ratio Rank: 2222
Omega Ratio Rank
ZEAL.CO Calmar Ratio Rank: 1818
Calmar Ratio Rank
ZEAL.CO Martin Ratio Rank: 99
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NKT.CO vs. ZEAL.CO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for NKT A/S (NKT.CO) and Zealand Pharma A/S (ZEAL.CO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


NKT.COZEAL.CODifference
Sharpe ratioReturn per unit of total volatility

+2.83

Sortino ratioReturn per unit of downside risk

+3.71

Omega ratioGain probability vs. loss probability

1.38

0.94

+0.44

Calmar ratioReturn relative to maximum drawdown

6.31

-0.67

+6.98

Martin ratioReturn relative to average drawdown

18.57

-1.39

+19.96

NKT.CO vs. ZEAL.CO - Sharpe Ratio Comparison

The current NKT.CO Sharpe Ratio is 2.28, which is higher than the ZEAL.CO Sharpe Ratio of -0.55. The chart below compares the historical Sharpe Ratios of NKT.CO and ZEAL.CO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

NKT.CO vs. ZEAL.CO - Drawdown Comparison

The maximum NKT.CO drawdown since its inception was -85.84%, which is greater than ZEAL.CO's maximum drawdown of -75.53%. Use the drawdown chart below to compare losses from any high point for NKT.CO and ZEAL.CO.


Loading charts...

Drawdown Indicators


NKT.COZEAL.CODifference

Max Drawdown

Largest peak-to-trough decline

-85.84%

-75.53%

-10.31%

Max Drawdown (1Y)

Largest decline over 1 year

-13.31%

-56.96%

+43.65%

Max Drawdown (3Y)

Largest decline over 3 years

-34.39%

-75.38%

+40.99%

Max Drawdown (5Y)

Largest decline over 5 years

-34.39%

-75.38%

+40.99%

Max Drawdown (10Y)

Largest decline over 10 years

-74.42%

-75.53%

+1.11%

Current Drawdown

Current decline from peak

-11.83%

-68.99%

+57.16%

Average Drawdown

Average peak-to-trough decline

-30.37%

-30.90%

+0.53%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.58%

28.60%

-24.02%

Volatility

NKT.CO vs. ZEAL.CO - Volatility Comparison

The current volatility for NKT A/S (NKT.CO) is 11.51%, while Zealand Pharma A/S (ZEAL.CO) has a volatility of 32.28%. This indicates that NKT.CO experiences smaller price fluctuations and is considered to be less risky than ZEAL.CO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NKT.COZEAL.CODifference

Volatility (1M)

Calculated over the trailing 1-month period

11.51%

32.28%

-20.77%

Volatility (6M)

Calculated over the trailing 6-month period

23.53%

63.18%

-39.65%

Volatility (1Y)

Calculated over the trailing 1-year period

36.90%

69.18%

-32.28%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

36.57%

61.52%

-24.95%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

40.60%

52.84%

-12.24%

Dividends

NKT.CO vs. ZEAL.CO - Dividend Comparison

Neither NKT.CO nor ZEAL.CO has paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
NKT.CO
NKT A/S
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%1.42%2.25%
ZEAL.CO
Zealand Pharma A/S
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

NKT.CO vs. ZEAL.CO - Financials Comparison

This section allows you to compare key financial metrics between NKT A/S and Zealand Pharma A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in DKK except per share items

Frequently Asked Questions


NKT.CO and ZEAL.CO have a correlation of 0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for NKT.CO and ZEAL.CO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer